SCHEMBL24952254

SCHEMBL24952254

Cc1ccc(C)c(NC(=O)c2cnc(Cl)nc2N(C)N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.47
▸ LMNA P02545 3/20 0.47
▸ TSHR P16473 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ NFKB1 P19838 2/20 0.46
▸ NFKB2 Q00653 2/20 0.46
▸ RELA Q04206 2/20 0.46
▸ HTT P42858 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ APOBEC3A P31941 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ APOBEC3G Q9HC16 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22145716 0.92 NPC1 (0.50) RAB9ANPC1SMN1; SMN2KDM4EMAPT
SCHEMBL24951632 0.84 RAB9A (0.52) RAB9ALMNATSHRHSD17B10NPC1
SCHEMBL30202682 0.83 ALDH1A1 (0.46) RAB9ALMNANPC1KDM4EMAPT
SCHEMBL24951831 0.83 ALDH1A1 (0.46) RAB9ALMNANPC1KDM4EMAPT
SCHEMBL20558385 0.82 RXFP1 (0.46) NFKB1NFKB2RELAMAPK1POLB
SCHEMBL20558515 0.82 NFKB1 (0.54) KDM4EMAPTNFKB1NFKB2RELA
SCHEMBL22145342 0.78 F10 (0.41) RAB9ANPC1SMN1; SMN2KDM4ENFKB1
SCHEMBL20558390 0.78 XPO1 (0.58) RAB9ALMNATSHRNPC1SMN1; SMN2
SCHEMBL31737724 0.78 PDE4D (0.42) —
SCHEMBL22145719 0.77 NFKB1 (0.48) RAB9ANPC1MAPTNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023007009-A1 PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-02-02 — — WO disclosed
Send feedback